It should be noted that hundreds of Mirena lawsuits are currently pending in courts around the country that allege spontaneous migration of the IUD caused women to suffer serious complications, some of which permanently affected their reproductive health.
New York, New York (PRWEB) August 28, 2014
As Mirena IUD lawsuits (http://www.themirenalawsuitcenter.com/) continue to mount in courts around the U.S., Bernstein Liebhard LLP notes that a new study in Obstetrics & Gynecology is touting devices like Mirena as ideal birth control for teenage girls. According to a report from The Daily Press, the authors of the study point out that IUDs are more reliable when it comes to preventing pregnancy than other methods favored by this patient population. Their study, which involved 2,500 women from the ages of 13 to 35, found that neither safety nor effectiveness was affected by the age of the IUD user. However, they did note that younger women were more likely to stop using an IUD after the first year, most likely due to pain and bleeding.*
“It should be noted that hundreds of Mirena lawsuits are currently pending in courts around the country that allege spontaneous migration of the IUD caused women to suffer serious complications, some of which permanently affected their reproductive health. Anyone considering Mirena, regardless of age, should be fully apprised of its potential risks,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to women who were allegedly harmed after their Mirena IUD spontaneously migrated from its proper position in the uterus.
Mirena IUD Lawsuits
The Mirena IUD was approved for contraception by the U.S. Food & Drug Administration (FDA) in 2000. In 2009, its approved uses were expanded to include the prevention of heavy menstrual bleeding in women who wish to use an IUD as their primary method of birth control. Among other things, the Mirena IUD is specifically recommended for women who have already given birth to at least one child.**
In December 2009, the FDA issued a Warning Letter to Bayer Healthcare Pharmaceuticals after finding that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD. Among other things, the FDA said the promotional materials wrongly implied that using the Mirena IUD would help a woman “look and feel great,” and improve her sex life. The FDA also asserted that the materials understated the risk of serious Mirena complications.
Court documents indicate that at least 968 Mirena lawsuits are currently pending in a consolidated litigation underway in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is actively filing claims. All of the complaints allege that recipients of the IUD experienced painful and debilitating injuries, including infertility, organ damage, and uterine perforations, as a result of spontaneous device migration. Among other things, the lawsuits allege that Bayer downplayed the risk of serious Mirena complications, and failed to warn that the IUD could migrate from its proper position in the uterus, even following correct insertion by a healthcare provider. (In Re: Mirena Litigation; Case No. 297)
In addition to the cases pending in New Jersey, court records show that hundreds of additional Mirena IUD lawsuits involving similar allegations have been filed in a federal multidistrict litigation now underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
Women who suffered serious Mirena complications allegedly due to spontaneous IUD migration may be entitled to compensation for their injury-related damages. To learn more, please visit Bernstein Liebhard LLP’s website, or visit the Firm’s Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.
*articles.dailypress.com/2014-08-26/health/dp-nws-riverside-iud-20140825_1_iud-paragard-mirena, Daily Press, August 26, 2014
**http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021225s027lbl.pdf, FDA, September 2009
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com